|
|
Blood, 1 May 2004, Vol. 103, No. 9, pp. 3590-3598.
Prepublished online as a Blood First Edition Paper on January 8, 2004; DOI 10.1182/blood-2003-08-2827.
 Previous Article | Table of Contents | Next Article 
TRANSPLANTATION
In vivo imaging of graft-versus-host-disease in mice
Angela Panoskaltsis-Mortari,
Andrew Price,
John R. Hermanson,
Elizabeth Taras,
Chris Lees,
Jonathan S. Serody, and
Bruce R. Blazar
From the Department of Pediatrics, Division of Hematology-Oncology, Blood and Marrow Transplant Program, University of Minnesota, Minneapolis; and Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill.
We have developed a mouse system by which to track the migration and homing of cells in a setting of bone marrow transplantation (BMT)-induced graft-versus-host disease (GVHD) after systemic infusion using enhanced green fluorescence protein (eGFP) transgenic (Tg) cells and a simple application of a fluorescence stereomicroscope outfitted with a color charge-coupled device (CCD) camera. Whole body images of anesthetized mice taken at various time points after cell infusion revealed the early migration of allogeneic cells to peripheral lymphoid organs, with later infiltration of GVHD target organs. Localization of eGFP Tg cells could be seen through the skin of shaved mice, and internal organs were easily discernible. After allogeneic or syngeneic eGFP Tg cell infusion, representative mice were dissected to better visualize deeper internal organs and tissues. Infusion of different cell populations revealed distinct homing patterns, and this method also provided a simple way to identify the critical time points for expansion of the transplanted cells in various organs. This simple application of the fluorescence stereomicroscope will be valuable for GVHD and graft-versus-tumor studies in which visualization of cellular migration, expansion, and cell-cell interactions will be more informative when analyzed by such an intravital method. (Blood. 2004;103:3590-3598)
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
G. Socie and B. R. Blazar
Acute graft-versus-host disease: from the bench to the bedside
Blood,
November 12, 2009;
114(20):
4327 - 4336.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. A. Olson, R. Zeiser, A. Beilhack, J. J. Goldman, and R. S. Negrin
Tissue-Specific Homing and Expansion of Donor NK Cells in Allogeneic Bone Marrow Transplantation
J. Immunol.,
September 1, 2009;
183(5):
3219 - 3228.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. Li, Y. Chen, W. He, T. Yi, D. Zhao, C. Zhang, C.-L. Lin, I. Todorov, F. Kandeel, S. Forman, et al.
Anti-CD3 preconditioning separates GVL from GVHD via modulating host dendritic cell and donor T-cell migration in recipients conditioned with TBI
Blood,
January 22, 2009;
113(4):
953 - 962.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. E. Anderson, P. A. Taylor, J. M. McNiff, D. Jain, A. J. Demetris, A. Panoskaltsis-Mortari, A. Ager, B. R. Blazar, W. D. Shlomchik, and M. J. Shlomchik
Effects of donor T-cell trafficking and priming site on graft-versus-host disease induction by naive and memory phenotype CD4 T cells
Blood,
May 15, 2008;
111(10):
5242 - 5251.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. K. Jasperson, C. Bucher, A. Panoskaltsis-Mortari, P. A. Taylor, A. L. Mellor, D. H. Munn, and B. R. Blazar
Indoleamine 2,3-dioxygenase is a critical regulator of acute graft-versus-host disease lethality
Blood,
March 15, 2008;
111(6):
3257 - 3265.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Beilhack, S. Schulz, J. Baker, G. F. Beilhack, R. Nishimura, E. M. Baker, G. Landan, E. I. Herman, E. C. Butcher, C. H. Contag, et al.
Prevention of acute graft-versus-host disease by blocking T-cell entry to secondary lymphoid organs
Blood,
March 1, 2008;
111(5):
2919 - 2928.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. D. Kim, T. H. Terwey, J. L. Zakrzewski, D. Suh, A. A. Kochman, M. E. Chen, C. G. King, C. Borsotti, J. Grubin, O. M. Smith, et al.
Organ-derived dendritic cells have differential effects on alloreactive T cells
Blood,
March 1, 2008;
111(5):
2929 - 2940.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Chakraverty and M. Sykes
The role of antigen-presenting cells in triggering graft-versus-host disease and graft-versus-leukemia
Blood,
July 1, 2007;
110(1):
9 - 17.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Serafini, S. J. Dylla, M. Oki, Y. Heremans, J. Tolar, Y. Jiang, S. M. Buckley, B. Pelacho, T. C. Burns, S. Frommer, et al.
Hematopoietic reconstitution by multipotent adult progenitor cells: precursors to long-term hematopoietic stem cells
J. Exp. Med.,
January 22, 2007;
204(1):
129 - 139.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Ueha, M. Murai, H. Yoneyama, M. Kitabatake, T. Imai, T. Shimaoka, S. Yonehara, S. Ishikawa, and K. Matsushima
Intervention of MAdCAM-1 or fractalkine alleviates graft-versus-host reaction associated intestinal injury while preserving graft-versus-tumor effects
J. Leukoc. Biol.,
January 1, 2007;
81(1):
176 - 185.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Chakraverty, D. Cote, J. Buchli, P. Cotter, R. Hsu, G. Zhao, T. Sachs, C. M. Pitsillides, R. Bronson, T. Means, et al.
An inflammatory checkpoint regulates recruitment of graft-versus-host reactive T cells to peripheral tissues
J. Exp. Med.,
August 7, 2006;
203(8):
2021 - 2031.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Vodanovic-Jankovic, P. Hari, P. Jacobs, R. Komorowski, and W. R. Drobyski
NF-{kappa}B as a target for the prevention of graft-versus-host disease: comparative efficacy of bortezomib and PS-1145
Blood,
January 15, 2006;
107(2):
827 - 834.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. A. Wysocki, Q. Jiang, A. Panoskaltsis-Mortari, P. A. Taylor, K. P. McKinnon, L. Su, B. R. Blazar, and J. S. Serody
Critical role for CCR5 in the function of donor CD4+CD25+ regulatory T cells during acute graft-versus-host disease
Blood,
November 1, 2005;
106(9):
3300 - 3307.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Beilhack, S. Schulz, J. Baker, G. F. Beilhack, C. B. Wieland, E. I. Herman, E. M. Baker, Y.-A. Cao, C. H. Contag, and R. S. Negrin
In vivo analyses of early events in acute graft-versus-host disease reveal sequential infiltration of T-cell subsets
Blood,
August 1, 2005;
106(3):
1113 - 1122.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. A. Wysocki, A. Panoskaltsis-Mortari, B. R. Blazar, and J. S. Serody
Leukocyte migration and graft-versus-host disease
Blood,
June 1, 2005;
105(11):
4191 - 4199.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Shukla, S. Yang, C. Milla, A. Panoskaltsis-Mortari, B. R. Blazar, and I. Y. Haddad
Absence of host tumor necrosis factor receptor 1 attenuates manifestations of idiopathic pneumonia syndrome
Am J Physiol Lung Cell Mol Physiol,
May 1, 2005;
288(5):
L942 - L949.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. A. Taylor, A. Panoskaltsis-Mortari, G. J. Freeman, A. H. Sharpe, R. J. Noelle, A. Y. Rudensky, T. W. Mak, J. S. Serody, and B. R. Blazar
Targeting of inducible costimulator (ICOS) expressed on alloreactive T cells down-regulates graft-versus-host disease (GVHD) and facilitates engraftment of allogeneic bone marrow (BM)
Blood,
April 15, 2005;
105(8):
3372 - 3380.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Paris and R. Sesboue
Metastasis models: the green fluorescent revolution?
Carcinogenesis,
December 1, 2004;
25(12):
2285 - 2292.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. A. Taylor, A. Panoskaltsis-Mortari, J. M. Swedin, P. J. Lucas, R. E. Gress, B. L. Levine, C. H. June, J. S. Serody, and B. R. Blazar
L-Selectinhi but not the L-selectinlo CD4+25+ T-regulatory cells are potent inhibitors of GVHD and BM graft rejection
Blood,
December 1, 2004;
104(12):
3804 - 3812.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. R. Blazar, R. B. Levy, T. W. Mak, A. Panoskaltsis-Mortari, H. Muta, M. Jones, M. Roskos, J. S. Serody, H. Yagita, E. R. Podack, et al.
CD30/CD30 Ligand (CD153) Interaction Regulates CD4+ T Cell-Mediated Graft-versus-Host Disease
J. Immunol.,
September 1, 2004;
173(5):
2933 - 2941.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. G. Sauer, M. E. Ericson, B. J. Weigel, M. J. Herron, A. Panoskaltsis-Mortari, B. T. Kren, B. L. Levine, J. S. Serody, C. H. June, P. A. Taylor, et al.
A Novel System for Simultaneous in Vivo Tracking and Biological Assessment of Leukemia Cells and ex Vivo Generated Leukemia-Reactive Cytotoxic T Cells
Cancer Res.,
June 1, 2004;
64(11):
3914 - 3921.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
